VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$172M
1-Year Est. Return
385.14%
This Fund
S&P 500
1 Year Est. Return
+385.14%
AUM
$172M
AUM Growth
+$65.4M
(+61%)
Holding
56
Top Buys
| 1 | +$9.52M | |
| 2 | +$8.75M | |
| 3 | +$3.91M | |
| 4 |
Protara Therapeutics
TARA
|
+$3.87M |
| 5 |
Verrica Pharmaceuticals
VRCA
|
+$2.61M |
Top Sells
| 1 | +$5.96M | |
| 2 | +$4.28M | |
| 3 | +$3.78M | |
| 4 |
uniQure
QURE
|
+$1.87M |
| 5 |
TELA Bio
TELA
|
+$1.11M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
uniQure
QURE
$1.11B
| – | – |
-32,000
|
|
||
|
52
TELA Bio
TELA
$27.9M
| – | – |
-747,410
|
|
||
|
TRML
53
DELISTED
Tourmaline Bio
TRML
| – | – |
-5,800
|
|
||
54
Wave Life Sciences
WVE
$1.39B
| – | – |
-15,000
|
|
||
|
ZOOZ
55
ZOOZ Strategy Ltd
ZOOZ
$52.6M
| – | – |
-2,000,000
|
|
||
|
ALMS
56
Alumis Inc
ALMS
$3.29B
| – | – |
-946,683
|
|